Antoni Ribas . Overcoming immunologic tolerance to melanoma : targeting CTLA-4 with tremelimumab ( CP4 wi , 206 ) . The Oncologist , 2008 , 13 : 10-15 .Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34 ( ......